Skip to content
healthcare.dev

dextroamphetamine sulfate

NDC 45963-305, dextroamphetamine sulfate, capsule, extended release, from Actavis Pharma, Inc..

Product NDC
45963-305
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203901
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45963-305 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROAMPHETAMINE SULFATE15 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
45963-305-094596303050990 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (45963-305-09)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9e92ccc3-d81c-461d-a19f-7e9b582be357
  • NADAC price for package 45963030509

    GET /v1/drugs/nadac/45963030509

Use it

Look up 45963-305 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45963-305 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45963-305. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.